Location History:
- Daejeon, KR (2016)
- Seoul, KR (2019)
Company Filing History:
Years Active: 2016-2019
Title: Saem Jung: Innovator in Protein Secretion Technology
Introduction
Saem Jung is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in protein secretion and expression vectors. With a total of 2 patents, his work has the potential to impact various applications in medicine and biotechnology.
Latest Patents
Saem Jung's latest patents include a "Protein secretory factor with high secretory efficiency and an expression vector comprising the same." This invention relates to a novel protein secretion factor, a vector that includes a nucleic acid sequence encoding the protein secretion factor, and a transformed cell into which the vector is introduced. The invention also outlines a method for producing a target protein using the transformed cell that contains the vector.
Another significant patent is the "Hybrid promoter and recombinant vector comprising the same." This invention describes a hybrid promoter that combines elements from a CMV enhancer, a β-actin promoter, a CMV promoter, and a β-actin intron. The recombinant vector, which includes this hybrid promoter, is designed to induce high expression of a target protein in eukaryotic cells. This technology can be effectively utilized for the development of antibodies or the production of DNA vaccines.
Career Highlights
Throughout his career, Saem Jung has worked with prominent companies such as LG Chem, Ltd. and LG Life Sciences, Limited. His experience in these organizations has contributed to his expertise in biotechnology and innovation.
Collaborations
Saem Jung has collaborated with notable coworkers, including Seung Hae Kim and Yeon Chul Kim. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Saem Jung is a distinguished inventor whose work in protein secretion technology and expression vectors holds promise for advancements in biotechnology. His patents reflect a commitment to innovation that could lead to significant breakthroughs in medical applications.